about
Ribophorin II is involved in the tissue factor expression mediated by phosphatidylserine-dependent antiprothrombin antibody on monocytes.Accurate quantitative assessment of synovitis in rheumatoid arthritis using pixel-by-pixel, time-intensity curve shape analysis.Engagement of SLAMF3 enhances CD4+ T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosusICER is requisite for Th17 differentiation.Successful treatment with tacrolimus of refractory adult-onset Still's disease.AAA-ATPase p97 suppresses apoptotic and autophagy-associated cell death in rheumatoid arthritis synovial fibroblasts.Prognosis and progress in immunotherapies for organ involvements in systemic autoimmune diseases.Power Doppler signal calibration in the finger joint between two models of ultrasound machine: a pilot study using a phantom and joints in patients with rheumatoid arthritis.Bi-ventricular interplay in patients with systemic sclerosis-associated pulmonary arterial hypertension: Detection by cardiac magnetic resonance.HLA-B52-positive Aortitis with Antineutrophil Cytoplasmic Antibody-associated Vasculitis.Palisaded neutrophilic and granulomatous dermatitis as a novel cause of hypercalcemia: A case report.Pixel-by-Pixel Arterial Spin Labeling Blood Flow Pattern Variation Analysis for Discrimination of Rheumatoid Synovitis: A Pilot Study.Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells.The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis.Long-term outcome in Japanese patients with lupus nephritis.Effectiveness of whole-body magnetic resonance imaging for the efficacy of biologic anti-rheumatic drugs in patients with rheumatoid arthritis: A retrospective pilot study.Projectile haemorrhage of a brachial artery in a patient with clinically amyopathic dermatomyositis.Anti-TIF1γ antibody predicted malignancy of thymic tumor with dermatomyositis as an "autoimmune tumor marker": A case reportCaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease.[Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs: 9. Mycophenolate mofetil]The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositisQuantification of hand synovitis in rheumatoid arthritis: Arterial mask subtraction reinforced with mutual information can improve accuracy of pixel-by-pixel time-intensity curve shape analysis in dynamic MRISerine/threonine phosphatase PP2A is essential for optimal B cell functionSignaling Lymphocytic Activation Molecule Family Member 1 Engagement Inhibits T Cell-B Cell Interaction and Diminishes Interleukin-6 Production and Plasmablast Differentiation in Systemic Lupus ErythematosusFactor Xa inhibitors for preventing recurrent thrombosis in patients with antiphospholipid syndrome: a longitudinal cohort studyPyruvate dehydrogenase phosphatase catalytic subunit 2 limits Th17 differentiationReduced diffusing capacity for carbon monoxide predicts borderline pulmonary arterial pressure in patients with systemic sclerosisMetabolic control of T cells in autoimmunityOptineurin in Synovial Fibroblasts Plays a Protective Role against Joint Destructions in Rheumatoid ArthritisRight ventricular dimension index by cardiac magnetic resonance for prognostication in connective tissue diseases and pulmonary hypertensionPyruvate kinase M2 is requisite for Th1 and Th17 differentiationGlutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis
P50
Q34514845-EAC2FD1E-A213-4CAD-9F82-E018A426A583Q37176563-E3B4D467-E145-4193-AFEA-56EC4E6FCC2FQ37200094-7244271B-CA36-4637-88F5-BF6BC3A08F53Q37324043-295AC027-ED28-4F3D-9962-13BD287F2E46Q37642233-435EA469-B794-4B7C-B829-A6E662600541Q37665634-AFD1FD08-26E4-41E0-BEA4-CFBAD59D9031Q38834945-62C0BCD1-89E6-433E-A8EB-EEA0AF3A48C5Q39022449-3535D20D-1429-4ACA-880D-0DCF48CE6C8FQ39479594-65DA5695-3256-48E3-AD6D-44066B262279Q40834107-CB6747D1-FD23-4CF5-AAB2-F09C88BC1A43Q42136250-185DE17A-4E22-4791-B5B8-272DB6B53F8FQ42359365-E25189E4-0E11-41E9-984D-5F7BB49BA85CQ49790388-4D382C11-E99A-445B-92C1-A51BAD0D2026Q50694526-D360C83C-6E0B-4A7B-BEB4-730DF05719EEQ53089425-0AE2A370-D4EA-4D33-A117-EC1BAE6A4440Q53549068-01730F40-D72E-4037-9FD2-CEA70D8CF338Q54269425-1AC49333-450D-4D31-B784-2A4694653203Q60961808-E8BD30D4-95D5-45E9-A7EA-87032360BC74Q64958442-E9306583-7208-4822-9F36-4DA72F7F145FQ82990969-D6E24D62-BF56-4B4C-A854-299755BF6EC3Q85391084-86BD7D44-A008-4ADD-85D1-250FD0ED869EQ87919743-4338B39B-1CE8-478F-B949-CA234B91AA8FQ90245041-71EEC862-3CDC-4737-975E-51C5C287DA1FQ90603949-4AA39610-9B5A-42F4-8C32-63EA9BFCFB0BQ90853935-7036EA86-7875-4D8D-A0BE-477BFE184D03Q91165070-FCB0A1F8-4B38-42FC-B76B-CFD3F821C50BQ91680492-3CE20876-6377-4C95-9234-E1E3465494D5Q92009976-4187450A-30EA-4DBC-A64E-1F0BA8956540Q92056189-DE94EA86-BC7E-48B5-B7C5-BDB4C92E3153Q92692625-51DAF580-31C2-4C4D-9BAF-11DA8F6FA1EAQ92884393-F01CCA5C-E687-45B7-B9B5-1A6934F52DB6Q92982542-E4B966BC-7E03-40E5-B0F9-A88FA0EAFBB0
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Michihito Kono
@en
Michihito Kono
@nl
type
label
Michihito Kono
@en
Michihito Kono
@nl
prefLabel
Michihito Kono
@en
Michihito Kono
@nl
P108
P31
P496
0000-0002-7663-534X